West Pharmaceutical Services (WST) Intangibles (2009 - 2026)

West Pharmaceutical Services (WST) has reported Intangibles for 18 consecutive years, with $6.4 million the latest figure, recorded in Q2 2026.

• Quarterly Intangibles fell 34.02% year-over-year to $6.4 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $6.4 million (down 34.02% YoY) and the FY2025 annual result came in at $7.7 million, down 28.7% from the prior year.
• Intangibles retreated to $6.4 million in Q2 2026 per WST's latest filing, from $7.0 million in the prior quarter.
• Over the last five years, Intangibles for WST reached as high as $21.8 million in Q1 2022 and fell as low as $6.4 million in Q2 2026.
• A 5-year average of $13.5 million and a median of $13.4 million in 2024 frame the typical range for Intangibles.
• Annual changes were most pronounced in 2023 — Intangibles fell 13.26% — and 2026, when it tumbled 34.02%.
• Year by year, Intangibles stood at $18.4 million in 2022, then retreated by 17.93% to $15.1 million in 2023, then retreated by 28.48% to $10.8 million in 2024, then dropped by 28.7% to $7.7 million in 2025, then decreased by 16.88% to $6.4 million in 2026.
• According to Business Quant data, Intangibles over the past three periods registered $6.4 million, $7.0 million, and $7.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.